EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation

Moli Wu, Danyang Song, Hui Li, Nisar Ahmad, Hong Xu, Xiaobo Yang iD, Qian Wang, Xiaoxin Cheng, Sa Deng, Xiaohong Shu iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Moli Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Dalian Medical University, Dalian 116044, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Science Project of Liaoning Provincial Education Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance blunts the efficacy of temozolomide (TMZ) in the treatment of glioblastoma (GBM). Elevated levels of O6-methylguanine-DNA methyltransferase (MGMT) and activation of signal transducer and of transcription 3 (STAT3) have been reported to correlate with GBM resistance to alkylator chemotherapy. Resveratrol (Res) inhibits tumor growth and improves drug chemosensitivity by targeting STAT3 signaling. Whether the combined therapy of TMZ and Res could enhance chemosensitivity against GBM cells and the underlying molecular mechanism remains to be determined. In this study, Res was found to effectively improve chemosensitivities of different GBM cells to TMZ, which was evaluated by CCK-8, flow cytometry, and cell migration assay. The combined use of Res and TMZ downregulated STAT3 activity and STAT3-regulated gene products, thus inhibited cell proliferation and migration, as well as induced apoptosis, accompanied by increased levels of its negative regulators: PIAS3, SHP1, SHP2, and SOCS3. More importantly, a combination therapy of Res and TMZ reversed TMZ resistance of LN428 cells, which could be related to decreased MGMT and STAT3 levels. Furthermore, the JAK2-specific inhibitor AG490 was used to demonstrate that a reduced MGMT level was mediated by STAT3 inactivation. Taken together, Res inhibited STAT3 signaling through modulation of PIAS3, SHP1, SHP2, and SOCS3, thereby attenuating tumor growth and increasing sensitivity to TMZ. Therefore, Res is an ideal candidate to be used in TMZ combined chemotherapy for GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaHumansAntineoplastic Agents, AlkylatingCell Line, TumorDNA Modification MethylasesDNA Repair EnzymesDrug Resistance, NeoplasmMolecular ChaperonesProtein Inhibitors of Activated STATResveratrolSTAT3 Transcription FactorSuppressor of Cytokine Signaling ProteinsTemozolomideTumor Suppressor Proteins

Stichwörter der Autor:innen

MGMTSTAT3STAT3 negative regulatorsglioblastomaresveratroltemozolomide

Substanzen

Antineoplastic Agents, AlkylatingDNA Modification MethylasesDNA Repair EnzymesMolecular ChaperonesProtein Inhibitors of Activated STATResveratrolSTAT3 Transcription FactorSuppressor of Cytokine Signaling ProteinsTemozolomideMGMT protein, human

Autor:innen und Institutionen

  • College of Pharmacy, Dalian Medical University, Dalian 116044, China.
  • College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
  • Key Laboratory for Basic and Applied Research on Pharmacodynamic Substances of Traditional Chinese Medicine of Liaoning Province, Dalian Medical University, Dalian 116044, China.

ORCID-Profile: Xiaobo Yang, Xiaohong Shu

Förderung

  • the National Natural Science Foundation of China
  • the Science Project of Liaoning Provincial Education Department

Zitieren

APA

Wu, M., Song, D., Li, H., Ahmad, N., Xu, H., Yang, X., Wang, Q., Cheng, X., Deng, S., & Shu, X. (2023). Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119453

Vancouver

Wu M, Song D, Li H, Ahmad N, Xu H, Yang X, et al. Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119453

BibTeX
@article{Wu2023,
  author = {Wu, Moli and Song, Danyang and Li, Hui and Ahmad, Nisar and Xu, Hong and Yang, Xiaobo and Wang, Qian and Cheng, Xiaoxin and Deng, Sa and Shu, Xiaohong},
  title = {Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119453}
}
Kostenlos starten →